The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study.
Mavropoulos JC1, Yancy WS, Hepburn J, Westman EC.
Author information
Abstract
BACKGROUND:

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age and is associated with obesity, hyperinsulinemia, and insulin resistance. Because low carbohydrate diets have been shown to reduce insulin resistance, this pilot study investigated the six-month metabolic and endocrine effects of a low-carbohydrate, ketogenic diet (LCKD) on overweight and obese women with PCOS.
RESULTS:

Eleven women with a body mass index >27 kg/m2 and a clinical diagnosis of PCOS were recruited from the community. They were instructed to limit their carbohydrate intake to 20 grams or less per day for 24 weeks. Participants returned every two weeks to an outpatient research clinic for measurements and reinforcement of dietary instruction. In the 5 women who completed the study, there were significant reductions from baseline to 24 weeks in body weight (-12%), percent free testosterone (-22%), LH/FSH ratio (-36%), and fasting insulin (-54%). There were non-significant decreases in insulin, glucose, testosterone, HgbA1c, triglyceride, and perceived body hair. Two women became pregnant despite previous infertility problems.
CONCLUSION:

In this pilot study, a LCKD led to significant improvement in weight, percent free testosterone, LH/FSH ratio, and fasting insulin in women with obesity and PCOS over a 24 week period.

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus.
Westman EC1, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR.
Author information

Abstract
OBJECTIVE:

Dietary carbohydrate is the major determinant of postprandial glucose levels, and several clinical studies have shown that low-carbohydrate diets improve glycemic control. In this study, we tested the hypothesis that a diet lower in carbohydrate would lead to greater improvement in glycemic control over a 24-week period in patients with obesity and type 2 diabetes mellitus.
RESEARCH DESIGN AND METHODS:

Eighty-four community volunteers with obesity and type 2 diabetes were randomized to either a low-carbohydrate, ketogenic diet (<20 g of carbohydrate daily; LCKD) or a low-glycemic, reduced-calorie diet (500 kcal/day deficit from weight maintenance diet; LGID). Both groups received group meetings, nutritional supplementation, and an exercise recommendation. The main outcome was glycemic control, measured by hemoglobin A1c.
RESULTS:

Forty-nine (58.3%) participants completed the study. Both interventions led to improvements in hemoglobin A1c, fasting glucose, fasting insulin, and weight loss. The LCKD group had greater improvements in hemoglobin A1c (-1.5% vs. -0.5%, p = 0.03), body weight (-11.1 kg vs. -6.9 kg, p = 0.008), and high density lipoprotein cholesterol (+5.6 mg/dL vs. 0 mg/dL, p < 0.001) compared to the LGID group. Diabetes medications were reduced or eliminated in 95.2% of LCKD vs. 62% of LGID participants (p < 0.01).
CONCLUSION:

Dietary modification led to improvements in glycemic control and medication reduction/elimination in motivated volunteers with type 2 diabetes. The diet lower in carbohydrate led to greater improvements in glycemic control, and more frequent medication reduction/elimination than the low glycemic index diet. Lifestyle modification using low carbohydrate interventions is effective for improving and reversing type 2 diabetes.

Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.
Feinman RD1, Pogozelski WK2, Astrup A3, Bernstein RK4, Fine EJ5, Westman EC6, Accurso A7, Frassetto L8, Gower BA9, McFarlane SI10, Nielsen JV11, Krarup T12, Saslow L13, Roth KS14, Vernon MC15, Volek JS16, Wilshire GB17, Dahlqvist A18, Sundberg R19, Childers A20, Morrison K21, Manninen AH22, Dashti HM23, Wood RJ24, Wortman J25, Worm N26.
Author information
Abstract

The inability of current recommendations to control the epidemic of diabetes, the specific failure of the prevailing low-fat diets to improve obesity, cardiovascular risk, or general health and the persistent reports of some serious side effects of commonly prescribed diabetic medications, in combination with the continued success of low-carbohydrate diets in the treatment of diabetes and metabolic syndrome without significant side effects, point to the need for a reappraisal of dietary guidelines. The benefits of carbohydrate restriction in diabetes are immediate and well documented. Concerns about the efficacy and safety are long term and conjectural rather than data driven. Dietary carbohydrate restriction reliably reduces high blood glucose, does not require weight loss (although is still best for weight loss), and leads to the reduction or elimination of medication. It has never shown side effects comparable with those seen in many drugs. Here we present 12 points of evidence supporting the use of low-carbohydrate diets as the first approach to treating type 2 diabetes and as the most effective adjunct to pharmacology in type 1. They represent the best-documented, least controversial results. The insistence on long-term randomized controlled trials as the only kind of data that will be accepted is without precedent in science. The seriousness of diabetes requires that we evaluate all of the evidence that is available. The 12 points are sufficiently compelling that we feel that the burden of proof rests with those who are opposed.

Silver Bullet
Отлично что смогли все пройти!
Вы наверно страховку сами покупаете, как селфимпл., так как я все подобное, кроме маркеров на рак, делала бесплатно от эндокринолога (BostonHeart Diagnostic), а вот за гормоны платила около $100.

Силвер буллет, анализы крови у вас были в норме?

девы, вот читаю вас и что-то подумываю тоже попробовать лоу карб.
Ситуация такая - рост 173 вес около 63 (138-139 lb) хочется похудеть до 130. Я особых диет не придерживаюсь просто ограничиваю сахар, не переедаю и хожу в спортзал. Вес посл год особо не меняется. Максимум падал до 136 и набирался обратно.
Еще в анамнезе язва желудка (с периодическими обострениями) - то есть голодать мне нельзя сразу жуткие боли.
Что скажете? Стоит ли в это дело вписываться?

P.S Aldi в округе нет :(

Я
Тоже вот в августе в Россию лечу, назначила тоже полное обслежование в одной из клиник, сказали за два дня утправлятся... ну посмотрим))

Aldi у нас есть, не оч близко правда... а так Трейдерс Джо, Пабликсы, всяко Фреш Маркеты и органические Роллинг Оатсы...

Кето оно разное может быть, смотрите что вам ближе. Кето может быть даже вегатерианским и веганским, может быть " чистым" без использования переработаных продуктов. Я лично ем и хотдоги, и салями и тд. Начните хотя бы с этого, там есть план и обзор продуктов и напитков.

https://www.walmart.com/ip/ReliOn-Keton ... 3=&veh=sem

Их можно разрезать вдоль на 2-3 , что бы хватало на дольше. Они достаточно широкие

Управятся! Я тоже не ожидала что так быстро. Это мы тут не привыкли к такому, а там это в порядке вещей... ... я поэтому в полном восторге, дешево и сердито. Может еще день зарезервируйте для дополнительных вещей если что найдут - если там какая то цитология понадобится или еще что. Спрашивайте где делают срочно, если что.

Я продукты только в Пабликсе и покупаю - там же все есть что надо. Может только если кому-то уж этих вафель или печенья очень хочется, то надо искать. А если вы к сладкому и мучному равнодушны (как я ) то в Паблике достаточно всего.